Vertex Pharmaceuticals price target raised to $560 by JPMorgan
JPMorgan raised its price target on Vertex Pharmaceuticals to $560 from $515,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.